The fact that ABA stimulates GLP-1 release accounts for considering ABA as a new possible strategy to impact on the GLP-1 axis in T2D, alone or in combination with DPP4 inhibitor. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.